Physician profile
Deborah Azar
NPI 1851471270
$8,573.47
in general payments reported to CMS, 2019-2025
44 companies · $893 in 2025
The $893 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,102 · 2020: $472 · 2021: $1,084 · 2022: $720 · 2023: $711 · 2024: $592 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,195.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,373.04 | 2019-2020 | |
| Astellas Pharma US INC | $715.91 | 2019-2025 | Xtandi |
| Abbvie INC. | $699.96 | 2019-2025 | Botox, Strattice Reconstructive Tissue Matrix Bps, Lupron Depot |
| Janssen Biotech, INC. | $610.19 | 2019-2025 | Erleada |
| Allergan, INC. | $609.25 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $418.62 | 2019-2025 | |
| Pfizer INC. | $281.91 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $210.59 | 2023-2025 | Gemtesa, Orgovyx |
| C. R. Bard, INC. & Subsidiaries | $175.20 | 2021 | |
| Urogen Pharma, INC. | $144.20 | 2021-2025 | Jelmyto |
| Ethicon US, LLC | $138.83 | 2019-2024 | Echelon Flex, Certus 140 |
| Coloplast Corp | $112.15 | 2019-2025 | Titan |
| Urovant Sciences INC | $93.20 | 2021-2022 | |
| Tela Bio, INC. | $67.44 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mission Pharmacal Company | $64.29 | 2020-2024 | Uribel Tabs, Uribel |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $61.43 | 2024-2025 | Eligard, Jatenzo |
| Pacira Pharmaceuticals Incorporated | $51.54 | 2021-2025 | Exparel, Iovera |
| Accord Healthcare, INC. | $50.39 | 2025 | |
| Medtronic, INC. | $49.48 | 2021-2022 | |
| Hollister Incorporated | $46.50 | 2021-2023 | Infyna Chic |
| Axonics, INC. | $42.67 | 2020-2021 | |
| Acera Surgical, INC. | $40.83 | 2024 | Restrata Wound Matrix |
| Cumberland Pharmaceuticals, INC. | $37.43 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $36.85 | 2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $34.62 | 2022 | |
| Blue Earth Diagnostics | $32.00 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $28.97 | 2020-2023 | Aveed, Xiaflex |
| Boston Scientific Corporation | $28.73 | 2025 | Axonics |
| Tempus Ai, INC | $27.88 | 2024 | |
| Myriad Genetic Laboratories, INC. | $26.77 | 2021 | |
| Baxter Healthcare | $24.51 | 2020 | |
| Procept Biorobotics Corporation | $24.25 | 2025 | |
| Myovant Sciences INC. | $23.07 | 2021 | |
| Dendreon Pharmaceuticals LLC | $22.77 | 2020 | |
| Integra Lifesciences Corporation | $22.20 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Reprise Biomedical, INC. | $19.98 | 2025 | Miro3d |
| Hologic Sales and Service, LLC | $19.94 | 2025 | Trunode, Magseed, Trident Specimen Radiography System |
| Standard Bariatrics, INC. | $17.65 | 2022 | |
| Olympus America INC. | $16.81 | 2023 | Itind System |
| Endo USA, INC. | $16.68 | 2025 | Xiaflex, Aveed |
| Bard Peripheral Vascular, INC. | $15.89 | 2021 | |
| Smith+Nephew, INC. | $14.86 | 2019 | |
| Covidien LP | $12.65 | 2019 | |
| Rochester Medical Corporation | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Azar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.